|
Name |
Methyl 14-methylpentadecanoate
|
Molecular Formula | C17H34O2 | |
IUPAC Name* |
methyl 14-methylpentadecanoate
|
|
SMILES |
CC(C)CCCCCCCCCCCCC(=O)OC
|
|
InChI |
InChI=1S/C17H34O2/c1-16(2)14-12-10-8-6-4-5-7-9-11-13-15-17(18)19-3/h16H,4-15H2,1-3H3
|
|
InChIKey |
WAKCWJNDXBPEBP-UHFFFAOYSA-N
|
|
Synonyms |
Methyl 14-methylpentadecanoate; 5129-60-2; Pentadecanoic acid, 14-methyl-, methyl ester; 14-Methylpentadecanoic acid methyl ester; METHYL14-METHYLPENTADECANOATE; Methyl isohexadecanoate; SCHEMBL2259435; DTXSID80199289; Methyl 14-methylpentadecanoate #; CHEBI:157641; ZINC4557092; FT-0751973; B960C1EE-F6EB-4C1B-A297-24FE1DAB2747; Q63395534
|
|
CAS | 5129-60-2 | |
PubChem CID | 21205 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 270.5 | ALogp: | 7.6 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 14 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 19 | QED Weighted: | 0.317 |
Caco-2 Permeability: | -4.656 | MDCK Permeability: | 0.00001540 |
Pgp-inhibitor: | 0.084 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.963 |
30% Bioavailability (F30%): | 0.977 |
Blood-Brain-Barrier Penetration (BBB): | 0.362 | Plasma Protein Binding (PPB): | 97.14% |
Volume Distribution (VD): | 1.571 | Fu: | 1.82% |
CYP1A2-inhibitor: | 0.467 | CYP1A2-substrate: | 0.207 |
CYP2C19-inhibitor: | 0.508 | CYP2C19-substrate: | 0.227 |
CYP2C9-inhibitor: | 0.362 | CYP2C9-substrate: | 0.964 |
CYP2D6-inhibitor: | 0.043 | CYP2D6-substrate: | 0.038 |
CYP3A4-inhibitor: | 0.356 | CYP3A4-substrate: | 0.095 |
Clearance (CL): | 5.61 | Half-life (T1/2): | 0.262 |
hERG Blockers: | 0.12 | Human Hepatotoxicity (H-HT): | 0.034 |
Drug-inuced Liver Injury (DILI): | 0.37 | AMES Toxicity: | 0.005 |
Rat Oral Acute Toxicity: | 0.026 | Maximum Recommended Daily Dose: | 0.015 |
Skin Sensitization: | 0.951 | Carcinogencity: | 0.068 |
Eye Corrosion: | 0.943 | Eye Irritation: | 0.965 |
Respiratory Toxicity: | 0.88 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001160 | 0.946 | D07ILQ | 0.468 | ||||
ENC001519 | 0.943 | D0Z5SM | 0.446 | ||||
ENC000848 | 0.898 | D0P1RL | 0.442 | ||||
ENC001142 | 0.817 | D05ATI | 0.429 | ||||
ENC001181 | 0.815 | D0G2KD | 0.402 | ||||
ENC001274 | 0.774 | D0O1PH | 0.400 | ||||
ENC000604 | 0.772 | D0T9TJ | 0.385 | ||||
ENC000549 | 0.746 | D00FGR | 0.376 | ||||
ENC000560 | 0.733 | D05QNO | 0.365 | ||||
ENC000916 | 0.724 | D00MLW | 0.356 |